Prelude Capital Management’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
Prelude Capital Management's RXST Position: Q3 2026 in Review
Prelude Capital Management reduced its RxSight (RXST) stake by 16% in Q3 2026, selling an estimated $49.7K and leaving 43,133 shares worth $211K. The position accounts for 0.02% of the portfolio, ranked #1067.
Prelude Capital Management first reported a position in RXST in Q1 2026 and has held it in 3 quarters since. The position peaked at $249K in Q2 2026. 156 funds tracked by Wall St. Rank hold RXST as of Q3 2026.
- Prelude Capital Management held 43,133 shares of RxSight worth $211K as of Q3 2026.
- Prelude Capital Management sold 8,467 RxSight shares in Q3 2026, an estimated $49.7K.
- RxSight made up 0.02% of Prelude Capital Management's portfolio in Q3 2026, its #1067 holding.
- Prelude Capital Management first reported a position in RxSight in Q1 2026 and has held it in 3 quarters since.
- Prelude Capital Management's RxSight position peaked at $249K in Q2 2026.
- 156 funds tracked by Wall St. Rank held RxSight as of Q3 2026.
Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.